Gefitinib

References

Citations

1. Health Canada (2006). Health Canada endorsed important safety information on Iressa (gefitinib) 250 mg tablets. Available online: http://hc-sc.gc.ca/dlhp-mps/medeff/advisories-avis/public/2006/iressa_2pc-cp_e.html.

2. Food and Drug Administration (2004). FDA statement on Iressa. FDA Public Health Web Notification. Available online: http://www.fda.gov/bbs/topics/news/2004/new01145.html.

Other Works Consulted

• Abramowicz M (2003). Treatment guidelines: Drugs of choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41–52.

Author:	Douglas Dana Shannon Erstad, MBA/MPH	Last Updated: August 30, 2006
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Tom Bailey, MD - Family Medicine Michael Seth Rabin, MD - Medical Oncology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.